Survey of prevalence of intestinal parasites in under hemodialysis patients referred to Sari and Zanjan hospitals, Iran


  • Salman Ghaffari Department of Medical Parasitology and Mycology, School of Medicine, Babol University of Medical Sciences, Babol, Iran
  • Ali Asghar Fazaeli Department of Medical Parasitology and Mycology, School of Medicine, Zanjan University of Medical Sciences, Zanjan, Iran
  • Roja Jafarian Department of General Medicine, Qeshm International School of Medicine, Qeshm International Free University, Qeshm, Iran
  • Farzane Jafarian Department of Medical Parasitology and Mycology, School of Medicine, Zanjan University of Medical Sciences Zanjan AND Clinical Research Development Unit of Rouhani Hospital, Babol University of Medical Sciences, Babol, Iran



Intestinal Parasites, Hemodialysis, Patients, Parasitic Infections


BACKGROUND: Patients undergoing hemodialysis are vulnerable to intestinal parasites due to a weakened immune system. This study aimed to determine the prevalence of intestinal parasites in patients undergoing hemodialysis.

METHODS: The feces of 168 under hemodialysis patients were collected from Sari and Zanjan hospitals, Iran, and the demographic and clinical information of the patients was recorded in a questionnaire. Samples were tested using wet-mount method, formalin-ether concentration, modified Ziehl-Neelsen staining for coccidia, conventional trichrome for intestinal protozoa, and modified trichrome for Microsporidia. Data were entered into SPSS software and analyzed by the chi-square test method (P < 0.05).

RESULTS: The prevalence of parasitic infections in patients under hemodialysis in Sari and Zanjan was 43.58% and 33.33%, respectively, with a total of 40.4%. With a prevalence of 23.28%, Giardia had the highest prevalence rate. Then, Entamoeba coli had a prevalence of 14.3% and other parasites were, respectively, Endolimax nana (6.54%), Blastocystis hominis, Entamoeba histolytica/dispar, Dientamoeba fragilis, and Cryptosporidium (each one: 1.19%), and Chilomastix mesnili (0.59%). There was no significant difference between the prevalence of intestinal parasites with age, gender, place of residence (urban or rural), and duration of hemodialysis (P ≤ 0.05).

CONCLUSION: Pathogenic parasites such as Giardia have a high prevalence in patients undergoing hemodialysis in Sari Region. Given the potential risks of these infections, especially giardiasis, amoebiasis, and cryptosporidiosis, it is recommended that regular screening be performed to diagnose and treat parasitic diseases in this population.


Vanholder R, Ringoir S. Infectious morbidity and defects of phagocytic function in end-stage renal disease: A review. J Am Soc Nephrol. 1993; 3(9): 1541-54.

Ocak S, Eskiocak AF. The evaluation of immune responses to hepatitis B vaccination in diabetic and non-diabetic haemodialysis patients and the use of tetanus toxoid. Nephrology (Carlton). 2008; 13(6): 487-91.

Dawson D. Foodborne protozoan parasites. Int J Food Microbiol. 2005; 103(2): 207-27.

Gholami SH, Hamzah Ali AA, Khalilian AR, Fakhar M, Gohardehi SH, Ahmadpour E. Frequency of cryptosporidiosis among gastroenteritic patients. J Mazandaran Univ Med Sci. 2012; 21(1): 261-70.

Ziaei Hezarjaribi H, Yousefi Z, Mohammadpour Tahamtan RA. Parasitic contamination of wells drinking water in Mazandaran Province in (2002- 2003). Behbood. 2006; 10(4 (31)): 378-88.

Kulik R, Falavigna D, Nishi L, Marques de Araujo S. Blastocystis sp and other intestinal parasites in hemodialysis patients. Braz J Infect Dis. 2008; 12(4): 338-41.

Taghipour A, Olfatifar M, Rostami A, Foroutan M, Vasigala V, Norouzi M. Intestinal parasites in hemodialysis patients from developing countries: A systematic review and meta-analysis. Hemodial Int. 2020; 24(1): 12-21.

Turkcapar N, Kutlay S, Nergizoglu G, Atli T, Duman N. Prevalence of Cryptosporidium infection in hemodialysis patients. Nephron. 2002; 90(3): 344-6.

Karadag G, Tamer GS, Dervisoglu E. Investigation of intestinal parasites in dialysis patients. Saudi Med J. 2013; 34(7): 714-8.

Elsayad MHM, Maharem DA, Ali FAS, Abd El-Latif NF. Detection of intestinal protozoan infections with stress on blastocystis, microsporidia in Egyptian chronic kidney disease patients. J Egypt Soc Parasitol. 2020; 50(3): 513-21.

Hazrati Tappeh K, Gharavi MJ, Makhdoumi K, Rahbar M, Taghizadeh A. Prevalence of Cryptosporidium spp. infection in renal transplant and hemodialysis patients. Iran J Public Health. 1970; 35(3): 54-7.

Seyrafian S, Pestehchian N, Kerdegari M, Yousefi HA, Bastani B. Prevalence rate of Cryptosporidium infection in hemodialysis patients in Iran. Hemodial Int. 2006; 10(4): 375-9.

Asadi N, Hazrati Tappeh K, Yousefi E, Khademvatan S. Differentiation of prevalent parasite from artifacts in parasitology laboratory. Iran J Med Microbiol. 2019; 13(2): 89-101.

Anders HJ, Wilkens L, Schraml B, Marschner J. One concept does not fit all: The immune system in different forms of acute kidney injury. Nephrol Dial Transplant. 2021; 36(1): 29-38.

Naeini AE, Sharifi M, Shahidi S, Taheri S, Seirafian S, Taheri D, et al. Intestinal fungal and parasitic infections in kidney transplant recipients: A multi-center study. Saudi J Kidney Dis Transpl. 2012; 23(4): 677-83.

Nasiri V, Esmailnia K, Karim G, Nasir M, Akhavan O. Intestinal parasitic infections among inhabitants of Karaj City, Tehran province, Iran in 2006-2008. Korean J Parasitol. 2009; 47(3): 265-8.

Lamarche C, Iliuta IA, Kitzler T. Infectious disease risk in dialysis patients: A transdisciplinary approach. Can J Kidney Health Dis. 2019; 6: 2054358119839080.

Seyrafian S, Pestehchian N, Namdari N, Aviani M, Kerdegari M, Parvizian F, et al. Prevalence of parasitic infections in Iranian stable hemodialysis patients. Appl Med Inform. 2011; 29(3): 31-6.

Shehata AI, Hassanein F, Abdul-Ghani R. Opportunistic parasitoses among Egyptian hemodialysis patients in relation to CD4+ T-cell counts: A comparative study. BMC Infect Dis. 2019; 19(1): 480.

Aldahhasi WT, Toulah FH, Wakid MH. Evaluation of common microscopic techniques for detection of blastocystis hominis. J Egypt Soc Parasitol. 2020; 50(1): 33-40.

Mardani KM, Tavalla M, Beiromvand M. Higher prevalence of Blastocystis hominis in healthy individuals than patients with gastrointestinal symptoms from Ahvaz, southwestern Iran. Comp Immunol Microbiol Infect Dis. 2019; 65: 160-4.

Oliveira YLDC, Oliveira LM, Oliveira YLM, Nascimento AMD, La Corte R, Geraldi RM, et al. Changes in the epidemiological profile of intestinal parasites after a school-based large-scale treatment for soil-transmitted helminths in a community in northeastern Brazil: Epidemiological profile after large-scale school-based treatment for STH. Acta Trop. 2020; 202: 105279.

Boreham PF, Stenzel DJ. Blastocystis in humans and animals: morphology, biology, and epizootiology. Adv Parasitol. 1993; 32: 1-70.

Stenzel DJ, Boreham PF. Blastocystis hominis revisited. Clin Microbiol Rev. 1996; 9(4): 563-84.

Izadi S, Mohaghegh MA, Ghayour-Najafabadi Z, Azami M, Mirzaei F, Namdar F, et al. Frequency and molecular identification of Cryptosporidium species among immunocompromised patients referred to hospitals, Central Iran, 2015-16. Iran J Parasitol. 2020; 15(1): 31-9.

Gerace E, Lo Presti VDM, Biondo C. Cryptosporidium Infection: Epidemiology, pathogenesis, and differential diagnosis. Eur J Microbiol Immunol (Bp). 2019; 9(4): 119-23.

Mosier DA, Oberst RD. Cryptosporidiosis. A global challenge. Ann N Y Acad Sci. 2000; 916: 102-11.

Botero JH, Castano A, Montoya MN, Ocampo NE, Hurtado MI, Lopera MM. A preliminary study of the prevalence of intestinal parasites in immunocompromised patients with and without gastrointestinal manifestations. Rev Inst Med Trop Sao Paulo. 2003; 45(4): 197-200.

El-Kady AM, Fahmi Y, Tolba M, Hashim AA, Hassan AA. Cryptosporidium infection in chronic kidney disease patients undergoing hemodialysis in Egypt. J Parasit Dis. 2018; 42(4): 630-5.

Mahmoudi MR, Hasani H, Mirzaei A. Study of intestinal protozoan in immunocompormised elderly patients in health care centers of Rasht city (2017). Journal of Geriatric Nursing. 2018; 4(4): 20-9.

Mahmoudi MR, Hasani H, Tsiami A, Ashrafi K, Johnson P, Sharifdini M, et al. Intestinal protozoan and helminthic infections among hemodialysis and cancer patients. Parasitol Res. 2020; 119(9): 3053-9.

Rosser JI, Blackburn BG. Pathogenic intestinal parasites in transplant recipients. In: Morris MI, Kotton CN, Wolfe CR, editors. Emerging transplant infections: clinical challenges and implications. Cham, Switzerland: Springer International Publishing; 2021. p. 1397-450.

Li Q, Yu S, Yang S, Yang W, Que S, Li W, et al. Eukaryotic community diversity and pathogenic eukaryotes in a full-scale drinking water treatment plant determined by 18S rRNA and metagenomic sequencing. Environ Sci Pollut Res Int. 2021; 28(14): 17417-30.

Furnkranz U, Walochnik J. Nosocomial Infections: Do not forget the parasites! Pathogens. 2021; 10(2).

Castro HZ, Borda JR, Linan HF, Manco JL, Wetzel EJ, Cardenas-Callirgos J. Notes on intestinal parasitic diseases in artisanal fishermen of the fishing terminal of Chorrillos (Lima, Peru). Neotropical Helminthology. 2013; 7(1): 155-66.

von Huth S, Thingholm LB, Kofoed PE, Bang C, Ruhlemann MC, Franke A, et al. Intestinal protozoan infections shape fecal bacterial microbiota in children from Guinea-Bissau. PLoS Negl Trop Dis. 2021; 15(3): e0009232.

Abdi J, Shams M, Visani Y, Karimiyan M, Kenarkoohi A. Prevalence of microsporidia in hiv-infected patients in iran: a meta-analysis and systematic review. J Ilam Univ Med Sci. 2020; 28(3): 21-8.

Deltombe C, Lefebvre M, Morio F, Boutoille D, Imbert BM, Le Pape P, et al. Cryptosporidiosis and microsporidiosis as causes of diarrhea in kidney and/or pancreas transplant recipients. Med Mal Infect. 2020; 50(5): 407-13.

Vivas RJ, Garcia JE, Guhl F, Hernandez C, Velasquez N, Ramirez JD, et al. Systematic review on the biology, ecology, genetic diversity and parasite transmission potential of Panstrongylus geniculatus (Latreille 1811) in Latin America. Mem Inst Oswaldo Cruz. 2021; 116: e200528.

Prior KF, Rijo-Ferreira F, Assis PA, Hirako IC, Weaver DR, Gazzinelli RT, et al. Periodic parasites and daily host rhythms. Cell Host Microbe. 2020; 27(2): 176-87.

Gwenzi W, Chaukura N, Muisa-Zikali N, Teta C, Musvuugwa T, Rzymski P, et al. Insects, rodents, and pets as reservoirs, vectors, and sentinels of antimicrobial resistance. Antibiotics (Basel). 2021; 10(1).

Diriba K, Awulachew E, Ashuro Z. Prevalence and antimicrobial resistance pattern of salmonella, shigella, and intestinal parasites and associated factor among food handlers in Dilla university student Cafeteria, Dilla, Ethiopia. Int J Microbiol. 2020; 2020: 3150539.

Mirzanejad-Asl H, Karimi A, Babaei PN, Moradi-Asl E. Spatio-temporal analysis and determination of the ecological niche model of Giardia Lamblia (Lambl, 1859) in Ardabil province, northwestern Iran. J Parasit Dis. 2021; 45(3): 706-14.




How to Cite

Ghaffari S, Fazaeli AA, Jafarian R, Jafarian F. Survey of prevalence of intestinal parasites in under hemodialysis patients referred to Sari and Zanjan hospitals, Iran. Chron Dis J. 2021;10(1):20–29.



Original Article(s)